Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-021622
Filing Date
2014-05-29
Accepted
2014-05-29 16:30:10
Documents
2
Period of Report
2014-05-28

Document Format Files

Seq Description Document Type Size
1 ROWLAND F3 5-28-14 rrd410473.html 3  
1 ROWLAND F3 5-28-14 rrd410473.xml 3 1592
2 POWER OF ATTORNEY rrd369645_418655.htm EX-24. 4906
  Complete submission text file 0001181431-14-021622.txt   8001
Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36072 | Film No.: 14876430

Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations